IHP Special Report

Patient Engagement: The New Frontier In Drug Development (Part 1)

August 21, 2015 at 10:53 AM
This is part one of an FDA Week Special Report on patient engagement in the drug development process. Part one focus on the methods FDA and other stakeholders are taking to better engage patients. Part two looks at the regulatory and technological hurdles involved in bringing real-world patient data into the drug development process. As policymakers and industry work to achieve the promise of 21st century cures, the barriers between pharmaceutical companies and the consumers they serve...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.